Advanced

Health-related quality of life in patients with different stages of liver disease induced by hepatitis C

Bjornsson, Einar; Verbaan, Hans LU ; Oksanen, Antti; Fryden, Aril; Johansson, Jonas; Friberg, Sarah; Dalgard, Olav and Kalaitzakis, Evangelos (2009) In Scandinavian Journal of Gastroenterology 44(7). p.878-887
Abstract
Objective. Patients with hepatitis C have been shown to have impaired health-related quality of life (HRQoL). The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis. Material and methods. Out of 489 consecutive patients who fulfilled the inclusion criteria, 472 (96%) agreed to participate in the study: 158 patients with mild/moderate fibrosis with chronic hepatitis C (CHC group), 76 patients with HCV compensated cirrhosis (CC), 53 patients with HCV decompensated (DC) cirrhosis, 52 non-cirrhotic patients with sustained viral response (SVR), and a control group consisting of 32 patients with non-HCV CC and 101 with non-HCV DC... (More)
Objective. Patients with hepatitis C have been shown to have impaired health-related quality of life (HRQoL). The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis. Material and methods. Out of 489 consecutive patients who fulfilled the inclusion criteria, 472 (96%) agreed to participate in the study: 158 patients with mild/moderate fibrosis with chronic hepatitis C (CHC group), 76 patients with HCV compensated cirrhosis (CC), 53 patients with HCV decompensated (DC) cirrhosis, 52 non-cirrhotic patients with sustained viral response (SVR), and a control group consisting of 32 patients with non-HCV CC and 101 with non-HCV DC who completed the Short Form-36 (SF-36) and EQ-5D questionnaire. Results. The CHC group had significantly lower SF-36 scores than healthy controls, with the exception of scores for the dimensions physical function and bodily pain. HCV patients with DC had lower scores in all SF-36 dimensions in comparison with those of the CHC group, as well as in physical and mental component summaries (P<0.001). In comparison with the CHC group, the HCV CC group had lower scores on the SF-36 general health dimension (p <0.05) and lower SF-36 physical component summary (PCS) scores (p <0.05). No major differences were seen in patients with HCV- and non-HCV-induced cirrhosis. Conclusions. Impairment in HRQoL in patients with HCV was associated with the severity of liver disease, patients with decompensated cirrhosis exhibiting the highest impairment in HRQoL. The etiology of liver disease does not seem to be important in determining HRQoL in cirrhosis. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
liver cirrhosis, Hepatitis C, liver, quality of life
in
Scandinavian Journal of Gastroenterology
volume
44
issue
7
pages
878 - 887
publisher
Taylor & Francis
external identifiers
  • wos:000268579400017
  • scopus:70350633007
ISSN
1502-7708
DOI
10.1080/00365520902898135
language
English
LU publication?
yes
id
85afa89d-34a0-4f5d-be2d-a5cc5c8a21cc (old id 1459485)
date added to LUP
2009-08-31 10:40:55
date last changed
2017-01-01 06:12:08
@article{85afa89d-34a0-4f5d-be2d-a5cc5c8a21cc,
  abstract     = {Objective. Patients with hepatitis C have been shown to have impaired health-related quality of life (HRQoL). The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis. Material and methods. Out of 489 consecutive patients who fulfilled the inclusion criteria, 472 (96%) agreed to participate in the study: 158 patients with mild/moderate fibrosis with chronic hepatitis C (CHC group), 76 patients with HCV compensated cirrhosis (CC), 53 patients with HCV decompensated (DC) cirrhosis, 52 non-cirrhotic patients with sustained viral response (SVR), and a control group consisting of 32 patients with non-HCV CC and 101 with non-HCV DC who completed the Short Form-36 (SF-36) and EQ-5D questionnaire. Results. The CHC group had significantly lower SF-36 scores than healthy controls, with the exception of scores for the dimensions physical function and bodily pain. HCV patients with DC had lower scores in all SF-36 dimensions in comparison with those of the CHC group, as well as in physical and mental component summaries (P&lt;0.001). In comparison with the CHC group, the HCV CC group had lower scores on the SF-36 general health dimension (p &lt;0.05) and lower SF-36 physical component summary (PCS) scores (p &lt;0.05). No major differences were seen in patients with HCV- and non-HCV-induced cirrhosis. Conclusions. Impairment in HRQoL in patients with HCV was associated with the severity of liver disease, patients with decompensated cirrhosis exhibiting the highest impairment in HRQoL. The etiology of liver disease does not seem to be important in determining HRQoL in cirrhosis.},
  author       = {Bjornsson, Einar and Verbaan, Hans and Oksanen, Antti and Fryden, Aril and Johansson, Jonas and Friberg, Sarah and Dalgard, Olav and Kalaitzakis, Evangelos},
  issn         = {1502-7708},
  keyword      = {liver cirrhosis,Hepatitis C,liver,quality of life},
  language     = {eng},
  number       = {7},
  pages        = {878--887},
  publisher    = {Taylor & Francis},
  series       = {Scandinavian Journal of Gastroenterology},
  title        = {Health-related quality of life in patients with different stages of liver disease induced by hepatitis C},
  url          = {http://dx.doi.org/10.1080/00365520902898135},
  volume       = {44},
  year         = {2009},
}